Thomas Quertermous
Corporate Officer/Principal chez Stanford University
Postes actifs de Thomas Quertermous
Sociétés | Poste | Début | Fin |
---|---|---|---|
Stanford University | Corporate Officer/Principal | 01/01/1997 | - |
Historique de carrière de Thomas Quertermous
Anciens postes connus de Thomas Quertermous
Sociétés | Poste | Début | Fin |
---|---|---|---|
BIOCARDIA INC | Directeur/Membre du Conseil | 01/01/2002 | 01/10/2019 |
Independent Dir/Board Member | 01/01/2002 | 01/10/2019 | |
Aviir, Inc.
Aviir, Inc. Medical/Nursing ServicesHealth Services Aviir, Inc. discovers, develops and commercializes diagnostic laboratory tests for cardiovascular diseases. The biotechnology company specializes in developing proprietary diagnostic tests to assist in identifying patients who are truly at high risk for the development of a cardiac event. The company was founded in 2005 and is headquartered in Irvine, CA. | Directeur/Membre du Conseil | 01/01/2006 | 16/04/2014 |
VIA Pharmaceuticals, Inc. /Old/
VIA Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology VIA Pharmaceuticals, Inc. develops pharmaceutical products. It focuses on small-molecule drugs that target inflammation in the blood vessel wall as an innovative approach to treatment of cardiovascular disease. The company's strategy is to identify, acquire and develop compounds that intervene in the process of vascular inflammation, to reduce the incidence of major cardiovascular events and provide a significant clinical benefit to patients. It was founded in June, 2004 by Thomas Quertermous, Adeoye Y. Olukotun and Douglass B. Given. VIA is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | 01/07/2004 | 07/06/2007 |
Fondateur | 01/07/2004 | 07/06/2007 | |
VIA PHARMACEUTICALS, INC. | Fondateur | 15/04/2015 | - |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Directeur/Membre du Conseil | 01/01/2002 | - |
Independent Dir/Board Member | 01/01/2002 | - | |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Vanderbilt University | Corporate Officer/Principal | - | - |
CAREDX, INC | Directeur/Membre du Conseil | - | - |
Formation de Thomas Quertermous
The University of Chicago | Doctorate Degree |
Grinnell College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 12 |
Opérationnelle
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Founder | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 5 |
Health Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
CAREDX, INC | Health Technology |
VIA PHARMACEUTICALS, INC. | Health Technology |
BIOCARDIA INC | Health Technology |
Entreprise privées | 4 |
---|---|
VIA Pharmaceuticals, Inc. /Old/
VIA Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology VIA Pharmaceuticals, Inc. develops pharmaceutical products. It focuses on small-molecule drugs that target inflammation in the blood vessel wall as an innovative approach to treatment of cardiovascular disease. The company's strategy is to identify, acquire and develop compounds that intervene in the process of vascular inflammation, to reduce the incidence of major cardiovascular events and provide a significant clinical benefit to patients. It was founded in June, 2004 by Thomas Quertermous, Adeoye Y. Olukotun and Douglass B. Given. VIA is headquartered in San Francisco, CA. | Health Technology |
Aviir, Inc.
Aviir, Inc. Medical/Nursing ServicesHealth Services Aviir, Inc. discovers, develops and commercializes diagnostic laboratory tests for cardiovascular diseases. The biotechnology company specializes in developing proprietary diagnostic tests to assist in identifying patients who are truly at high risk for the development of a cardiac event. The company was founded in 2005 and is headquartered in Irvine, CA. | Health Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Health Technology |
- Bourse
- Insiders
- Thomas Quertermous
- Expérience